alexa Osteoarthritis: From Physiotherapy to Advanced-Therapy Medicinal Products and Back Again | OMICS International | Abstract
ISSN: 2165-7025

Journal of Novel Physiotherapies
Open Access

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Review Article

Osteoarthritis: From Physiotherapy to Advanced-Therapy Medicinal Products and Back Again

Joaquim Vives*, Marta Caminal and Arnau Pla*
Divisió de Teràpies Avançades / XCELIA, Banc de Sang i Teixits, Edifici Dr. Frederic Duran i Jorda, Passeig Taulat, 116, 08005 Barcelona, Spain
Corresponding Authors : Joaquim Vives
de Divisió Teràpies Avançades/XCELIA
Banc de Sang i Teixits
Edifici Dr. Frederic Duran i Jorda
Passeig Taulat, 116, 08005 Barcelona, Spain
Tel: +34 93 5573500, Ext. 6708
E-mail: [email protected]
  Arnau Pla
de Divisió Teràpies Avançades / XCELIA
Banc de Sang i Teixits
Edifici Dr. Frederic Duran i Jorda
Passeig Taulat, 116, 08005 Barcelona, Spain
Tel: +34 93 5573500, Ext. 6701
E-mail: [email protected]
Received February 25, 2013; Accepted March 25, 2013; Published March 27, 2013
Citation: Vives J, Caminal M, Pla A (2013) Osteoarthritis: From Physiotherapy to Advanced–Therapy Medicinal Products and Back Again. J Nov Physiother 3:128. doi:10.4172/2165-7025.1000128
Copyright: © 2013 Vives J, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Abstract

Aging and injuries can lead to damage to articular cartilage, which can eventually result in impaired joint function. Osteoarthritis is a painful and sometimes disabling condition considered a public health concern that represents the leading osteoarticular pathology in developed countries. It is difficult to manage with current treatment options. Physiotherapeutic and pharmacological interventions mainly focus on pain relief and improvement of joint function whilst surgical approaches do not successfully restore hyaline articular cartilage. The worldwide demand for therapies to promote the efficient resolution of articular cartilage damage may be approached by tissue-engineering techniques due to the complexity of pathologies involving two types of distinct tissues (articular cartilage and subchondral bone) with their own particular biomechanical and biochemical characteristics. In addition to outlining established treatments of osteoarticular pathology, we will also discuss recent advances in the orthopaedic field that had led to the start of clinical trials for novel cell-based therapies.

Keywords

Recommended Conferences
Share This Page
Top